• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3,4-二氨基吡啶治疗前后兰伯特-伊顿肌无力综合征的刺激单纤维肌电图

Stimulated single-fiber electromyography in Lambert-Eaton myasthenic syndrome before and after 3,4-diaminopyridine.

作者信息

Sadeh M, River Y, Argov Z

机构信息

Department of Neurology, Sheba Medical Center, Tel Hashomer, Israel.

出版信息

Muscle Nerve. 1997 Jun;20(6):735-9. doi: 10.1002/(sici)1097-4598(199706)20:6<735::aid-mus11>3.0.co;2-t.

DOI:10.1002/(sici)1097-4598(199706)20:6<735::aid-mus11>3.0.co;2-t
PMID:9149081
Abstract

A patient with LEMS unrelated to cancer was studied by stimulated single-fiber electromyography (SFEMG) before and 3 months after the onset of therapy with 3,4-diaminopyridine. All end-plates showed a progressive reduction in blockings and jitter with the increase in stimulation rate. Treatment significantly corrected this feature, but the overall pattern of frequency-improved jitter remained. Such widespread finding is rare but diagnostic for Lambert-Eaton myasthenic syndrome. Stimulated SFEMG can be used to monitor therapy in such patients.

摘要

一名与癌症无关的兰伯特-伊顿肌无力综合征(LEMS)患者,在接受3,4-二氨基吡啶治疗前及治疗开始3个月后,接受了单纤维肌电图(SFEMG)检查。随着刺激频率增加,所有终板的阻滞和颤抖均呈进行性减少。治疗显著纠正了这一特征,但频率改善的颤抖总体模式仍然存在。这种广泛存在的表现虽罕见,但对兰伯特-伊顿肌无力综合征具有诊断意义。刺激SFEMG可用于监测此类患者的治疗情况。

相似文献

1
Stimulated single-fiber electromyography in Lambert-Eaton myasthenic syndrome before and after 3,4-diaminopyridine.3,4-二氨基吡啶治疗前后兰伯特-伊顿肌无力综合征的刺激单纤维肌电图
Muscle Nerve. 1997 Jun;20(6):735-9. doi: 10.1002/(sici)1097-4598(199706)20:6<735::aid-mus11>3.0.co;2-t.
2
Single-fiber electromyography improvement with 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome.
Muscle Nerve. 1998 Aug;21(8):1107-8. doi: 10.1002/(sici)1097-4598(199808)21:8<1107::aid-mus27>3.0.co;2-p.
3
3,4-Diaminopyridine (DAP) in the treatment of Lambert-Eaton myasthenic syndrome (LEMS).3,4-二氨基吡啶(DAP)治疗兰伯特-伊顿肌无力综合征(LEMS)。
Ann N Y Acad Sci. 1998 May 13;841:811-6. doi: 10.1111/j.1749-6632.1998.tb11022.x.
4
3,4-Diaminopyridine, an orphan drug, in the symptomatic treatment of Lambert-Eaton myasthenic syndrome.3,4-二氨基吡啶,一种孤儿药,用于兰伯特-伊顿肌无力综合征的对症治疗。
Pflugers Arch. 1996;431(6 Suppl 2):R295-6. doi: 10.1007/BF02346385.
5
Effect of 3,4-diaminopyridine on the time course of decay of compound muscle action potential augmentation in the Lambert-Eaton myasthenic syndrome.3,4-二氨基吡啶对兰伯特-伊顿肌无力综合征中复合肌肉动作电位增强衰减时间进程的影响。
Muscle Nerve. 1998 Sep;21(9):1196-8. doi: 10.1002/(sici)1097-4598(199809)21:9<1196::aid-mus11>3.0.co;2-q.
6
Single motor end-plates in myasthenia gravis and LEMS at different firing rates.重症肌无力和兰伯特-伊顿肌无力综合征中不同放电频率下的单个运动终板
Muscle Nerve. 1991 Mar;14(3):226-32. doi: 10.1002/mus.880140305.
7
3,4-Diaminopyridine in Lambert-Eaton myasthenic syndrome and myasthenia gravis.3,4-二氨基吡啶治疗兰伯特-伊顿肌无力综合征和重症肌无力。
Ann N Y Acad Sci. 1993 Jun 21;681:588-90. doi: 10.1111/j.1749-6632.1993.tb22949.x.
8
Treatment for Lambert-Eaton myasthenic syndrome.兰伯特-伊顿肌无力综合征的治疗。
Cochrane Database Syst Rev. 2011 Feb 16;2011(2):CD003279. doi: 10.1002/14651858.CD003279.pub3.
9
Neurogenic bladder in Lambert-Eaton myasthenic syndrome and its response to 3,4-diaminopyridine.
J Neurol Sci. 2001 Jan 15;183(1):1-4. doi: 10.1016/s0022-510x(00)00460-3.
10
[Long-term treatment of Lambert-Eaton syndrome by 3, 4 diaminopyridine].
Rev Neurol (Paris). 1992;148(12):776-9.